Molly Ware, MD
Cardiovascular Disease · Boulder, CONPI 1700863545
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,500 of the $21,265 with a category attached, or 82.3%. Boston Scientific accounts for 94.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $10,961 and has fallen 52.1% since, to $5,246 in 2025. Among cardiovascular disease clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 52 payments — averaging $408.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$20K
- Abbott$811
- Heartflow, Inc.$158
- Medtronic$124
- Biosense Webster, Inc.$33
- Edwards Lifesciences$29
- plus $14 from 1 others
What the payments were for
- Speaking & faculty fees$17,50082%
- Travel & lodging$2,61112%
- Food & beverage$1,1545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 34 | $20,095 |
| Abbott | 7 | $811 |
| Heartflow, Inc. | 2 | $158 |
| Medtronic | 6 | $124 |
| Biosense Webster, Inc. | 1 | $33 |
| Edwards Lifesciences | 1 | $29 |
| Atricure, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$19,327
- FFRct$142
- Watchman$112
How this compares
$21,265 in reported general payments places this provider in the 90th percentile of 276 cardiovascular disease providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 256 | $376,072 |
| Repatha SureclickEvolocumab | 43 | $43,318 |
| JardianceEmpagliflozin | 27 | $38,587 |
| XareltoRivaroxaban | 16 | $18,916 |
| Praluent PenAlirocumab | 11 | $14,388 |
| Metoprolol Succinate | 331 | $4,320 |
| Atorvastatin Calcium | 390 | $3,845 |
| Nebivolol Hcl | 46 | $3,626 |
| Rosuvastatin Calcium | 323 | $3,306 |
| Losartan Potassium | 342 | $2,611 |
| Ezetimibe | 71 | $2,264 |
| Amlodipine Besylate | 199 | $1,372 |
| InvokanaCanagliflozin | 12 | $1,198 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 30 | $1,195 |
| Carvedilol | 107 | $966 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Boulder
- Payal KohliAurora$1.7M
- Marc BonacaAurora$703K
- Andrew FreemanDenver$454K
- William SauerAurora$365K
- Jeffrey BooneGreenwood Village$287K
- Rhonda MiyasakaAurora$128K
- Gregory SchwartzAurora$122K
- Deborah JalowiecColorado Springs$106K
- Edward GillAurora$96K
- Sameer MehtaDenver$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.